Cell and Gene Therapy Global Market Report 2026

Description

Gene therapy involves the transmission of genetic material, typically in the form of a carrier or vector, and the uptake of the gene into the proper body cells. Cell therapy includes introducing cells into the patient with the appropriate function. Some procedures combine cell therapy with gene therapy.

The main types of products in cell and gene therapies are cell therapy and gene therapy. Gene therapy is a branch of medicine that focuses on modifying the genetic material of cells to achieve a therapeutic effect or to heal disease by repairing or reconstructing damaged genetic material. The different applications include oncology, dermatology, musculoskeletal, and others and involve various sectors such as hospitals, ambulatory surgical centers, cancer care centers, wound care centers, and others.

Tariffs have impacted the cell and gene therapy market by raising the cost of imported viral vectors, laboratory reagents, and specialized delivery equipment. Segments like CAR-T cell therapy and viral vector-based gene therapy are most affected, with North America, Europe, and Asia-Pacific regions like China and India facing significant import duties. This has increased operational costs and slowed therapy deployment. On the positive side, tariffs have encouraged local manufacturing, investment in domestic R&D, and innovation in cost-effective therapy delivery systems.

The cell and gene therapy market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy market statistics, including cell and gene therapy industry global market size, regional shares, competitors with a cell and gene therapy market share, detailed cell and gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy industry. This cell and gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell and gene therapy market size has grown exponentially in recent years. It will grow from $21.33 billion in 2025 to $26.21 billion in 2026 at a compound annual growth rate (CAGR) of 22.9%. The growth in the historic period can be attributed to limited availability of cell and gene therapies, reliance on conventional treatment modalities, high cost of early-generation therapies, growing incidence of oncology and neurological disorders, lack of specialized treatment centers.

The cell and gene therapy market size is expected to see exponential growth in the next few years. It will grow to $60.58 billion in 2030 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to development of advanced car-t and genome editing therapies, expansion of clinical trials and research programs, increasing adoption of personalized medicine, rising government support and funding for rare disease treatments, integration of digital platforms for therapy monitoring and patient management. Major trends in the forecast period include increasing adoption of car-t and stem cell therapies, rising investment in gene therapy for oncology and rare diseases, growth in personalized and targeted cell-based treatments, expansion of hospital and ambulatory surgical centers offering advanced therapies, integration of genome editing and viral vector-based technologies in clinical practice.

A growing number of ongoing clinical trials is expected to propel the growth of the cell and gene therapy market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trials play a vital role in the development and advancement of cell and gene therapy. They provide a safe and controlled environment to test new therapies and collect data on their safety and efficacy. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, a growing number of ongoing clinical trials is driving the growth of the cell and gene therapy market.

Major companies operating in the cell and gene therapy market are increasing their focus on introducing agnostic systems to gain a competitive edge in the market. Agnostic systems refer to systems that are integrated with a variety of different cell and gene therapy (CGT) software platforms, as well as biopharmaceutical or provider-facing platforms. For instance, in April 2023, AmerisourceBergen, a US-based healthcare company, launched the Cell and Gene Therapy Integration Hub, a new platform-agnostic system that aims to improve connectivity across the cell and gene therapy (CGT) treatment journey to enable an enhanced patient and provider experience. The hub is powered by the company's customer relationship management system and is designed to speed up the benefits investigation process, give a real-time view of therapy development and transportation status, and assist in coordinating patient support.

In January 2024, Kyowa Kirin Co., Ltd., a Japan-based pharmaceutical company that develops and sells drugs to improve human health and well-being worldwide, acquired Orchard Therapeutics for an undisclosed amount. With this acquisition, Kyowa Kirin Co. Ltd. aims to enhance its capabilities in developing innovative gene therapies for rare diseases, expanding its therapeutic portfolio, and addressing unmet medical needs. Orchard Therapeutics plc is a UK-based biotech company that specializes in developing innovative cell and gene therapies.

Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca

North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell and gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell and gene therapy market includes revenues earned by entities treating cancer, cystic fibrosis, heart disease, diabetes, hemophilia, and AIDS. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell and Gene Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell and gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell and gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product: Cell Therapy; Gene Therapy
2) By Application: Oncology; Neurological Disorders; Other Applications
3) By End User: Hospitals; Ambulatory Surgical Centers; Cancer Care Centers; Wound Care Centers; Other End-Users
Subsegments:
1) By Cell Therapy: Autologous Cell Therapy; Allogeneic Cell Therapy; Stem Cell Therapy; CAR-T Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy; Non-Viral Vector-Based Gene Therapy; Genome Editing Technologies; Antisense Oligonucleotide Therapy
Companies Mentioned: Biogen Inc.; Novartis AG; Gilead Sciences; Ionis Pharmaceuticals Inc.; Alnylam Pharmaceuticals Inc.; ArrowHead Pharmaceuticals Inc.; Spark Therapeutics; Bluebird Bio Inc.; RegenexBio; Mesoblast Limited; Stempeutics Research Pvt. Ltd.; EdiGene Inc.; Takara Bio; Oxford Biomedica plc; Merck; GenScript; Cellular Biomedicine Group; inStem; Bristol-Myers Squibb; Amgen; Pfizer; Kite Pharma; Freeline Therapeutics; PsiOxus Therapeutics; Herantis Pharma Plc; AstraZeneca
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH5MCGTE01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Cell and Gene Therapy Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Cell and Gene Therapy Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Cell and Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Cell and Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Car-T And Stem Cell Therapies
- 4.2.2 Rising Investment In Gene Therapy For Oncology And Rare Diseases
- 4.2.3 Growth In Personalized And Targeted Cell-Based Treatments
- 4.2.4 Expansion Of Hospital And Ambulatory Surgical Centers Offering Advanced Therapies
- 4.2.5 Integration Of Genome Editing And Viral Vector-Based Technologies In Clinical Practice

5. Cell and Gene Therapy Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Ambulatory Surgical Centers
5.3 Cancer Care Centers
5.4 Wound Care Centers
5.5 Specialty Research & Treatment Institutes

6. Cell and Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell and Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cell and Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cell and Gene Therapy Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cell and Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cell and Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell and Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell and Gene Therapy Market Segmentation

9.1. Global Cell and Gene Therapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cell Therapy, Gene Therapy
9.2. Global Cell and Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Neurological Disorders, Other Applications
9.3. Global Cell and Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
9.4. Global Cell and Gene Therapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy
9.5. Global Cell and Gene Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy

10. Cell and Gene Therapy Market Regional And Country Analysis

10.1. Global Cell and Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Cell and Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell and Gene Therapy Market

11.1. Asia-Pacific Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell and Gene Therapy Market

12.1. China Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell and Gene Therapy Market

13.1. India Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell and Gene Therapy Market

14.1. Japan Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell and Gene Therapy Market

15.1. Australia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell and Gene Therapy Market

16.1. Indonesia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell and Gene Therapy Market

17.1. South Korea Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell and Gene Therapy Market

18.1. Taiwan Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell and Gene Therapy Market

19.1. South East Asia Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell and Gene Therapy Market

20.1. Western Europe Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell and Gene Therapy Market

21.1. UK Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell and Gene Therapy Market

22.1. Germany Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell and Gene Therapy Market

23.1. France Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell and Gene Therapy Market

24.1. Italy Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell and Gene Therapy Market

25.1. Spain Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell and Gene Therapy Market

26.1. Eastern Europe Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell and Gene Therapy Market

27.1. Russia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell and Gene Therapy Market

28.1. North America Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell and Gene Therapy Market

29.1. USA Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell and Gene Therapy Market

30.1. Canada Cell and Gene Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell and Gene Therapy Market

31.1. South America Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell and Gene Therapy Market

32.1. Brazil Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell and Gene Therapy Market

33.1. Middle East Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell and Gene Therapy Market

34.1. Africa Cell and Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell and Gene Therapy Market Regulatory and Investment Landscape

36. Cell and Gene Therapy Market Competitive Landscape And Company Profiles

36.1. Cell and Gene Therapy Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Cell and Gene Therapy Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Cell and Gene Therapy Market Company Profiles
- 36.3.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Gilead Sciences Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Ionis Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cell and Gene Therapy Market Other Major And Innovative Companies

ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen

38. Global Cell and Gene Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell and Gene Therapy Market

40. Cell and Gene Therapy Market High Potential Countries, Segments and Strategies

40.1 Cell and Gene Therapy Market In 2030 - Countries Offering Most New Opportunities
40.2 Cell and Gene Therapy Market In 2030 - Segments Offering Most New Opportunities
40.3 Cell and Gene Therapy Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer